KRAS Mouse Monoclonal Antibody [A8E5]
Usd: 350 Special Discount
Specification
Catalog# HA601059
KRAS Mouse Monoclonal Antibody [A8E5]
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_HA601059_Europe.pdf
- No MSDS Found
Overview
Product Name
KRAS Mouse Monoclonal Antibody [A8E5]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Recombinant protein within human KRAS aa 2-186.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IHC-P, FC
Target Molecular Weight
Predicted band size: 22 kDa
Positive Control
HCT 116 cell lysate, HEK-293 cell lysate, 22RV1 cell lysate, Mouse brain tissue lysate, Mouse kidney tissue lysate, Rat brain tissue lysate, Jurkat, NIH/3T3, human lung carcinoma tissue.
Conjugation
unconjugated
Clone Number
A8E5
RRID
Reactivity Data
Verified (internally validated)
Reported in literature (not internally validated)
Predicted reactive (based on sequence homology)
Not recommended (failed internal validation)
| WB | IHC-P | FC | IF-Cell | |
|---|---|---|---|---|
| human |
|
|
|
|
| mouse |
|
|
|
|
| rat |
|
|
|
|
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IF-Cell
-
1:100
-
IHC-P
-
1:1100
-
FC
-
1:500-1:1,000
Target
Function
The K-Ras protein is a GTPase, a class of enzymes which convert the nucleotide guanosine triphosphate (GTP) into guanosine diphosphate (GDP). In this way the K-Ras protein acts like a switch that is turned on and off by the GTP and GDP molecules. To transmit signals, it must be turned on by attaching (binding) to a molecule of GTP. The K-Ras protein is turned off (inactivated) when it converts the GTP to GDP. When the protein is bound to GDP, it does not relay signals to the cell's nucleus. Several germline KRAS mutations have been found to be associated with Noonan syndrome and cardio-facio-cutaneous syndrome. Somatic KRAS mutations are found at high rates in leukemias, colorectal cancer, pancreatic cancer and lung cancer. KRAS mutations are more commonly observed in cecal cancers than colorectal cancers located in any other places from ascending colon to rectum. KRAS gene can also be amplified in colorectal cancer. Tumors or cell lines harboring this genetic lesion are not responsive to EGFR inhibitors. Although KRAS amplification is an infrequent event in colorectal cancer, it might be responsible for precluding response to anti-EGFR treatment in some patients. Amplification of wild-type Kras has also been observed in ovarian, gastric, uterine, and lung cancers. Driver mutations in KRAS underlie the pathogenesis of up to 20% of human cancers. Hence KRAS is an attractive drug target, however lack of obvious binding sites has hindered pharmaceutical development. One potential drug interaction site is where GTP/GDP binds. However, due to the extraordinarily high affinity of GTP/GDP for this site, it is unlikely that drug-like small molecule inhibitors could compete with GTP/GDP binding. Other than where GTP/GDP binds, there are no obvious high affinity binding sites for small molecules.
Background References
1. Christophe Rosty et al. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol. 2013 Jun;26(6):825-34. doi: 10.1038/modpathol.2012.240. Epub 2013 Jan 25.
2. N Tsuchida, T Ryder, E Ohtsubo. Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus. Science. 1982 Sep 3;217(4563):937-9. doi: 10.1126/science.6287573.
Subcellular Location
Cell membrane. Cytoplasm.
Synonyms
c Ki ras2 antibody
c Kirsten ras protein antibody
c-K-ras antibody
c-Ki-ras antibody
Cellular c Ki ras2 proto oncogene antibody
Cellular transforming proto oncogene antibody
CFC2 antibody
cK Ras antibody
GTPase KRas antibody
K RAS p21 protein antibody
Expandc Ki ras2 antibody
c Kirsten ras protein antibody
c-K-ras antibody
c-Ki-ras antibody
Cellular c Ki ras2 proto oncogene antibody
Cellular transforming proto oncogene antibody
CFC2 antibody
cK Ras antibody
GTPase KRas antibody
K RAS p21 protein antibody
K RAS2A antibody
K RAS2B antibody
K RAS4A antibody
K RAS4B antibody
K-Ras 2 antibody
KI RAS antibody
Ki-Ras antibody
KIRSTEN MURINE SARCOMA VIRUS 2 antibody
Kirsten rat sarcoma 2 viral (v Ki ras2) oncogene homolog antibody
Kirsten rat sarcoma viral oncogene homolog antibody
KRAS antibody
KRAS proto oncogene, GTPase antibody
KRAS1 antibody
KRAS2 antibody
N-terminally processed antibody
NS antibody
NS3 antibody
Oncogene KRAS2 antibody
p21ras antibody
PR310 c K ras oncogene antibody
PR310 cK ras oncogene antibody
RALD antibody
RASK_HUMAN antibody
RASK2 antibody
Transforming protein p21 antibody
v Ki ras2 Kirsten rat sarcoma 2 viral oncogene homolog antibody
v Ki ras2 Kirsten rat sarcoma viral oncogene homolog antibody
CollapseImages
-
Western blot analysis of KRAS on different lysates with Mouse anti-KRAS antibody (HA601059) at 1/2,000 dilution.
Lane 1: HCT 116 cell lysate
Lane 2: HEK-293 cell lysate
Lane 3: 22RV1 cell lysate
Lane 4: Mouse brain tissue lysate
Lane 5: Mouse kidney tissue lysate
Lane 6: Rat brain tissue lysate
Lysates/proteins at 30 µg/Lane.
Predicted band size: 22 kDa
Observed band size: 22 kDa
Exposure time: 3 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601059) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of Jurkat cells labeling KRAS with Mouse anti-KRAS antibody (HA601059) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-KRAS antibody (HA601059) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) were used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of NIH/3T3 cells labeling KRAS with Mouse anti-KRAS antibody (HA601059) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-KRAS antibody (HA601059) at 1/100 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. -
Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue with Mouse anti-KRAS antibody (HA601059) at 1/1,100 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601059) at 1/1,100 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Flow cytometric analysis of Jurkat cells labeling KRAS.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA601059, 1/1,000) (red) compared with Mouse IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Flow cytometric analysis of NIH/3T3 cells labeling KRAS.
Cells were fixed and permeabilized, and then blocked with 2% negative goat serum for 15 minutes at room temperature.Then stained with the primary antibody (HA601059, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Citation
-
Delivery of small interfering RNA through lyophilized natural lipid nanoparticles: effects of natural lipid selection
Journal: Pharmaceutical Biology
DOI: 10.1080/13880209.2025.2498169
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2025 May
-
RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth
Journal: Nature Structural & Molecular Biology
DOI:
IF: 16.8
Application: WB
Reactivity: Human
Publish date: 2024 May
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Alternative Products
KRAS Recombinant Mouse Monoclonal Antibody [A8E6]
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Products with the same target and pathway
KRAS Recombinant Mouse Monoclonal Antibody [A8E6] - BSA and Azide free
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
KRAS Mouse Monoclonal Antibody [A8E4]
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
KRAS Rabbit Polyclonal Antibody
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
KRAS Recombinant Mouse Monoclonal Antibody [A8E6]
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated